Navigation Links
BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Date:7/17/2008

royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that MBP8298 will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medical announces its intention to renew a normal course issuer bid
2. BioMS Medical to present at BioContact 2007
3. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
4. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
5. BioMS Medical announces third quarter 2007 results
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
9. BioMS Medical to present at BIO CEO & Investor Conference
10. BioMS Medical Announces 2007 Year End Results
11. BioMS Medical to present at BioCentury Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/14/2009)... - Results From a Survey Conducted by ... Major Industrialized Countries , , - A ... impacts their enjoyment of the ... arthritis find shopping for gifts, ... difficult to do, ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... December 2009 -- Researchers have discovered a new explanation for ... more excess copies of a certain gene, the more serious ... and it is suspected that it is the amount of ... are being published in the American Journal of Human ... group of Guy Froyen connected to VIB, a life sciences ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2
... Enoch, S. Guenneau and A.B. Movchan , ... building stronger ocean-based structures to withstand tsunamis, it ... disappear. A collaboration of physicists from the Centre ... Universite in France and the University of Liverpool ...
... PharmAthene, Inc.,(Amex: PIP ), a biodefense company ... today that the National,Institute of Allergy and Infectious ... (NIH), has awarded the Company a multi-year contract,for ... a third generation,recombinant protective antigen (rPA) anthrax vaccine., ...
... and VERNON HILLS, Ill., Sept. 26 ,Winston Laboratories, ... of products for pain management, and Getting Ready ... GTRY), completed,a merger on September 25, 2008, pursuant ... Winston with and into Winston Acquisition Corp., a,wholly-owned ...
Other Biology Technology:Tsunami invisibility cloak, dark energy v. the void, sorting nanotubes with light, and more 2Tsunami invisibility cloak, dark energy v. the void, sorting nanotubes with light, and more 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 2PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 3PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 4PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 5PharmAthene Awarded NIAID Contract For Up to $83.9 Million For Third Generation rPA Anthrax Vaccine Program 6Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 2Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 3Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 4
(Date:12/14/2009)... diseases can be transmitted by sneezing, touching, or ... face, a habit that may have driven the dinosaurs ... , Jacqueline Upcroft, a member of f1000 Biology, highlights ... published in PLoS One. This led them to deduce ... diseased jaw bones seen in many tyrannosaurid fossils. , ...
(Date:12/14/2009)... 2009If you are spending the holidays with big Uncle ... would be better off with another family, spare a ... research team from McMaster University and the University of ... species that lives in groups, members make strategic decisions ... in the current issue of Biology Letters . ...
(Date:12/14/2009)... Nations Framework Convention on Climate Change taking place ... ,Bend the Trend, event on Sunday evening to ... the screening of the new ,Environmental Atlas of ... joint project of the European Environment Agency (EEA), ... a series of short films showing the significance ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 1Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 2Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 3Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries 13711 4Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 1Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 2Anesthetix Launches OPTIMETRIX 28TM 29 Perioperative Quality Management Tool 55473 3
... Cellulose--a fibrous molecule found in all plants--is the ... also a favored target of renewable, plant-based biofuels ... about how plant cells synthesize individual cellulose fibers. ... Department of Plant Biology and Stanford University describes ...
... engineering at New Jersey Institute of Technology (NJIT) who is ... two grants that will help her bring the promise of ... , Arinzeh received a $700,000 grant from the New ... funds spinal cord research. She will use the grant to ...
... When medics are treating trauma patients, every second counts. ... it difficult to locate veins and administer lifesaving drugs ... Institute of Technology researchers is developing an inexpensive, handheld ... quickly. , "Depth and angle are the critical ...
Other Biology News:Formation of cellulose fibers tracked for the first time 2NJIT engineer poised to take stem cell research a step forward 2NJIT engineer poised to take stem cell research a step forward 3Researchers develop portable 'vein finder' for faster, more accurate injections 2Researchers develop portable 'vein finder' for faster, more accurate injections 3
NPT1 (M-19)...
... These versatile vacuum cups provide ... smooth, curved, or irregular surfaces. ,PFG: ... Short Bellows cup ,PCG: Multiple Bellows ... typically from 25 to 200 mm ...
8 different frozen tissues are mounted on positively charged glass slides...
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
Biology Products: